Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,225 | 375 | 99.8% |
| Education | $12.02 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,030 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $737.09 | 48 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $668.56 | 43 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $528.33 | 33 | $0 (2022) |
| Novo Nordisk Inc | $476.91 | 30 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $427.87 | 19 | $0 (2023) |
| AbbVie Inc. | $319.79 | 17 | $0 (2023) |
| PFIZER INC. | $297.22 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $260.04 | 20 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $249.84 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.64 | 5 | PFIZER INC. ($68.49) |
| 2023 | $987.84 | 53 | Lilly USA, LLC ($249.39) |
| 2022 | $1,052 | 62 | Lilly USA, LLC ($228.33) |
| 2021 | $1,036 | 57 | Lilly USA, LLC ($163.58) |
| 2020 | $806.77 | 52 | SANOFI-AVENTIS U.S. LLC ($142.81) |
| 2019 | $839.36 | 49 | AstraZeneca Pharmaceuticals LP ($157.54) |
| 2018 | $836.39 | 56 | GlaxoSmithKline, LLC. ($150.08) |
| 2017 | $585.74 | 43 | Janssen Pharmaceuticals, Inc ($119.91) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 11/22/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/29/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Neuroscience | ||||||
| 08/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 08/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Biological | ||||||
| 08/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,219 | 2,027 | $161,685 | $96,301 |
| 2022 | 12 | 1,379 | 2,262 | $184,609 | $106,179 |
| 2021 | 10 | 800 | 1,038 | $66,414 | $43,929 |
| 2020 | 5 | 423 | 611 | $32,980 | $13,860 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 620 | $88,660 | $49,623 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 285 | $29,925 | $15,535 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $14,345 | $11,606 | 80.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 633 | $9,495 | $5,317 | 56.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 76 | 76 | $5,320 | $5,214 | 98.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $4,095 | $2,709 | 66.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,508 | $1,726 | 68.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 89 | 89 | $2,136 | $1,531 | 71.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 76 | $1,520 | $1,490 | 98.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 29 | 29 | $1,595 | $969.36 | 60.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 18 | $666.00 | $233.22 | 35.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 42 | 67 | $670.00 | $228.47 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $750.00 | $120.56 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 332 | 670 | $95,810 | $53,881 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 339 | $35,595 | $19,125 | 53.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $12,986 | $10,836 | 83.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 86 | 87 | $6,090 | $5,963 | 97.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 80 | 111 | $6,105 | $4,801 | 78.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 21 | $6,615 | $4,310 | 65.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 326 | 652 | $9,780 | $1,931 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 87 | 88 | $1,760 | $1,725 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,352 | $1,670 | 31.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 60 | 60 | $1,440 | $1,048 | 72.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 49 | 68 | $2,516 | $697.37 | 27.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 37 | 56 | $560.00 | $192.76 | 34.4% |
About Dr. Gregory Stamper, DO
Dr. Gregory Stamper, DO is a Internal Medicine healthcare provider based in Williston, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790765592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Stamper, DO has received a total of $6,237 in payments from pharmaceutical and medical device companies, with $92.64 received in 2024. These payments were reported across 377 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,225).
As a Medicare-enrolled provider, Stamper has provided services to 3,821 Medicare beneficiaries, totaling 5,938 services with total Medicare billing of $260,270. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Williston, FL
- Active Since 01/18/2006
- Last Updated 11/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790765592
Products in Payments
- TRULICITY (Drug) $530.52
- FARXIGA (Drug) $462.36
- TRELEGY ELLIPTA (Drug) $413.28
- HETLIOZ (Drug) $310.91
- JARDIANCE (Drug) $263.24
- MOUNJARO (Drug) $252.86
- Ozempic (Drug) $231.32
- ELIQUIS (Drug) $217.81
- SOLIQUA 100/33 (Biological) $192.17
- Rybelsus (Drug) $174.98
- XARELTO (Drug) $164.01
- EMGALITY (Drug) $161.23
- TOUJEO (Drug) $148.60
- JANUVIA (Drug) $141.73
- VRAYLAR (Drug) $127.17
- ANORO (Drug) $114.15
- SYMBICORT (Drug) $102.85
- QULIPTA (Drug) $102.67
- INVOKANA (Drug) $96.03
- Fanapt (Drug) $89.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Williston
Dr. Donald Mccoy, Do, DO
Internal Medicine — Payments: $5,732
Dr. Bruce Pugatch, Md, MD
Internal Medicine — Payments: $687.15
Mr. Samiollah Gholam, M.d, M.D
Internal Medicine — Payments: $212.12
Anne Brena, Md, MD
Internal Medicine — Payments: $77.65
George Wilson, Md, MD
Internal Medicine — Payments: $51.13
Dr. John Clair, Do, DO
Internal Medicine — Payments: $37.18